GeoVax Labs, Inc. (GOVX)
0.505
-0.05
(-8.60%)
USD |
NASDAQ |
Sep 03, 16:00
0.5202
+0.02
(+3.01%)
After-Hours: 20:00
GeoVax Labs Shareholders Equity (Quarterly) : 1.761M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.761M |
| March 31, 2026 | 0.4938M |
| December 31, 2025 | 3.825M |
| September 30, 2025 | 4.907M |
| June 30, 2025 | 2.821M |
| March 31, 2025 | 7.898M |
| December 31, 2024 | 5.048M |
| September 30, 2024 | 8.504M |
| June 30, 2024 | -2.309M |
| March 31, 2024 | 0.0543M |
| December 31, 2023 | 5.763M |
| September 30, 2023 | 9.119M |
| June 30, 2023 | 17.16M |
| March 31, 2023 | 22.87M |
| December 31, 2022 | 26.60M |
| September 30, 2022 | 31.78M |
| June 30, 2022 | 27.87M |
| March 31, 2022 | 11.35M |
| December 31, 2021 | 4.362M |
| September 30, 2021 | 18.00M |
| June 30, 2021 | 19.46M |
| March 31, 2021 | 20.65M |
| December 31, 2020 | 9.569M |
| September 30, 2020 | 10.81M |
| June 30, 2020 | -1.850M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.864M |
| December 31, 2019 | -1.575M |
| September 30, 2019 | -1.021M |
| June 30, 2019 | -1.329M |
| March 31, 2019 | -1.207M |
| December 31, 2018 | -1.022M |
| September 30, 2018 | -0.7242M |
| June 30, 2018 | -0.7427M |
| March 31, 2018 | -0.1289M |
| December 31, 2017 | -0.3211M |
| September 30, 2017 | -0.2359M |
| June 30, 2017 | 0.3384M |
| March 31, 2017 | -0.2442M |
| December 31, 2016 | 0.2404M |
| September 30, 2016 | 0.4226M |
| June 30, 2016 | 0.1589M |
| March 31, 2016 | 0.63M |
| December 31, 2015 | 1.205M |
| September 30, 2015 | 1.880M |
| June 30, 2015 | 2.483M |
| March 31, 2015 | 3.142M |
| December 31, 2014 | 1.146M |
| September 30, 2014 | 0.8829M |
| June 30, 2014 | 1.283M |
| March 31, 2014 | 1.938M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.643M |
| Total Liabilities (Quarterly) | 2.882M |
| Debt to Equity Ratio | 0.1835 |
| Current Ratio | 1.539 |
| Net Debt Paydown Yield | -0.69% |